Evidence map›Paper›PMID 27288692›Full record

ArticleCarcinogenesis2016

Genetic variant in DNA repair gene GTF2H4 is associated with lung cancer risk: a large-scale analysis of six published GWAS datasets in the TRICL consortium.

Meilin Wang, Hongliang Liu, Zhensheng Liu, Xiaohua Yi, Heike Bickeboller, Rayjean J Hung, Paul Brennan, Maria Teresa Landi, Neil Caporaso, David C Christiani and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Carcinogenesis, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 3 pooled it
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 3 syntheses or guidelines pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Genetic modifiers of cognitive decline in PSEN1 E280A Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
    Article
  8. Etiology of lung cancer: Evidence from epidemiologic studies.Journal of the National Cancer Center · 2022
    Review
  9. Article
  10. Article
  11. Article
  12. A Decade of GWAS Results in Lung Cancer.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2018
    Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 9 institutions in 5 countries.

Meilin WangDuke Cancer Institute, Duke University Medical Center, 905 Lasalle Street, Durham, NC 27710, USA.
Hongliang LiuDuke Cancer Institute, Duke University Medical Center, 905 Lasalle Street, Durham, NC 27710, USA.
Zhensheng LiuDuke Cancer Institute, Duke University Medical Center, 905 Lasalle Street, Durham, NC 27710, USA.
Xiaohua YiDuke Cancer Institute, Duke University Medical Center, 905 Lasalle Street, Durham, NC 27710, USA.
Heike BickebollerDepartment of Genetic Epidemiology, University Medical Center, Georg-August-University Göttingen , 37073 Göttingen , Germany.
Rayjean J HungLunenfeld-Tanenbaum Research Institute of Mount Sinai hospital , Toronto, Ontario , Canada.
Paul BrennanGenetic Epidemiology Group, International Agency for Research on Cancer , 69372 Lyon , France.
Maria Teresa LandiDivision of Cancer Epidemiology and Genetics, National Cancer Institute , Bethesda, MD 20892 , USA.
Neil CaporasoDivision of Cancer Epidemiology and Genetics, National Cancer Institute , Bethesda, MD 20892 , USA.
David C ChristianiDepartment of Environmental Health and.
Jennifer Anne DohertyCommunity and Family Medicine, Geisel School of Medicine, Dartmouth College , Hanover, NH 03756 , USA.
TRICL Research Team
Christopher I AmosCommunity and Family Medicine, Geisel School of Medicine, Dartmouth College , Hanover, NH 03756 , USA.
Qingyi WeiDuke Cancer Institute, Duke University Medical Center, 905 Lasalle Street, Durham, NC 27710, USA.
Dartmouth College · USDivision of Cancer Epidemiology and GeneticsDuke Medical Center · USDuke University · USCentre International de Recherche sur le Cancer · FRHarvard University · USLunenfeld-Tanenbaum Research Institute · CANanjing Medical University · CNUniversity of Göttingen · DE

Funding

Women's Cancer Research ProgramP30CA014236 · NCI · DUKE UNIVERSITY · PI JOHN N. NORTON · 1985 to 2026
$174.8M
Translational Engineering in Cancer (TEC)P30CA023108 · NCI · DARTMOUTH COLLEGE · PI Fred W Kolling IV · 1985 to 2026
$91.3M
UNIVERSITY OF TEXAS--SPORE IN LUNG CANCERP50CA070907 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI HEYMACH, JOHN V., MINNA, JOHN D. · 1996 to 2024
$57.4M
JH/CIDR Genotyping for Genome-Wide Association StudiesU01HG004438 · NHGRI · JOHNS HOPKINS UNIVERSITY · PI VALLE, DAVID · 2007 to 2011
$24.2M
THE CAROTENE AND RETINOL EFFICACY TRIAL (CARET)U01CA063673 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI GOODMAN, GARY E · 1994 to 2006
$13.0M
Translational studies of Hsp90 inhibitors in NSCLCP50CA090578 · NCI · DANA-FARBER CANCER INST · PI YEAP, BEOW Y · 2008 to 2012
$11.4M
Statistical Methods for Analysis of Massive Genetic and Genomic Data in Cancer ResearchR35CA197449 · NCI · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI XIHONG LIN · 2015 to 2026
$10.9M
Transdisciplinary Research in Cancer of the Lung (TRICL)U19CA148127 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI AMOS, CHRISTOPHER I., LE MARCHAND, LOIC · 2010 to 2014
$10.9M
Genome Wide Association Coordinating CenterU01HG004446 · NHGRI · UNIVERSITY OF WASHINGTON · PI WEIR, BRUCE S. · 2007 to 2011
$6.6M
Molecular and Genetic Analysis of Lung Cancer SurvivalR01CA092824 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI CHRISTIANI, DAVID C · 2002 to 2013
$5.9M
ECOGENETIC STUDY OF LUNG CANCER IN MINORITIESR01CA055769 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI SPITZ, MARGARET R · 1991 to 2008
$5.3M
SPORE in Lung CancerP20CA090578 · NCI · DANA-FARBER CANCER INSTITUTE · PI JOHNSON, BRUCE E. · 2003 to 2007
$5.1M
Cancer Research UK C1298/A8362Cancer Research UK C1298/A8780NCI NIH HHS K07 CA160753NCI NIH HHS N01 CN25404NCI NIH HHS N01 CN25476NCI NIH HHS N01 CN25511NCI NIH HHS N01 CN25512NCI NIH HHS N01 CN25513NCI NIH HHS N01 CN25514NCI NIH HHS N01 CN25515NCI NIH HHS N01 CN25516NCI NIH HHS N01 CN25518NCI NIH HHS N01 CN25522NCI NIH HHS N01 CN25524NCI NIH HHS N01 CN75022NCI NIH HHS P20 CA090578NCI NIH HHS P30 CA014236NCI NIH HHS P30 CA023108NCI NIH HHS P50 CA070907NCI NIH HHS P50 CA090578NCI NIH HHS R01 CA055769NCI NIH HHS R01 CA074386NCI NIH HHS R01 CA092039NCI NIH HHS R01 CA092824NCI NIH HHS R01 CA111703NCI NIH HHS R01 CA121197NCI NIH HHS R01 CA127219NCI NIH HHS R01 CA133996NCI NIH HHS R01 CA151989NCI NIH HHS R35 CA197449NCI NIH HHS U01 CA063673NCI NIH HHS U19 CA148127NHGRI NIH HHS HHSN268200782096CNHGRI NIH HHS U01 HG004438NHGRI NIH HHS U01 HG004446World Health Organization 001
6 · The paper itself

Abstract

DNA repair pathways maintain genomic integrity and stability, and dysfunction of DNA repair leads to cancer. We hypothesize that functional genetic variants in DNA repair genes are associated with risk of lung cancer. We performed a large-scale meta-analysis of 123,371 single nucleotide polymorphisms (SNPs) in 169 DNA repair genes obtained from six previously published genome-wide association studies (GWASs) of 12160 lung cancer cases and 16838 controls. We calculated odds ratios (ORs) with 95% confidence intervals (CIs) using the logistic regression model and used the false discovery rate (FDR) method for correction of multiple testing. As a result, 14 SNPs had a significant odds ratio (OR) for lung cancer risk with P FDR < 0.05, of which rs3115672 in MSH5 (OR = 1.20, 95% CI = 1.14-1.27) and rs114596632 in GTF2H4 (OR = 1.19, 95% CI = 1.12-1.25) at 6q21.33 were the most statistically significant (P combined = 3.99×10(-11) and P combined = 5.40×10(-10), respectively). The MSH5 rs3115672, but not GTF2H4 rs114596632, was strongly correlated with MSH5 rs3131379 in that region (r (2) = 1.000 and r (2) = 0.539, respectively) as reported in a previous GWAS. Importantly, however, the GTF2H4 rs114596632 T, but not MSH5 rs3115672 T, allele was significantly associated with both decreased DNA repair capacity phenotype and decreased mRNA expression levels. These provided evidence that functional genetic variants of GTF2H4 confer susceptibility to lung cancer.

Indexed as

Genetic Predisposition to DiseasePolymorphism, Single NucleotideCell Cycle ProteinsDNA RepairGenetic VariationGenome-Wide Association StudyHumansLung NeoplasmsRiskTranscription Factor TFIIHCell Cycle ProteinsMSH5 protein, humanTranscription Factor TFIIH

Identifiers

PMID27288692
PMCPMC5008248
OpenAlexW2414891484

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.